Lotus Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2008 Results

Lotus Pharmaceuticals, Inc a pharmaceutical company in the People's Republic of China ("PRC"), today announced that it will conduct a conference call at 9:00 a.m. Eastern Standard Time on Tuesday, November 18, 2008 to discuss results for the quarter ended September 30, 2008.

Joining Dr. Zhongyi Liu, Chairman and Chief Executive Officer of Lotus Pharmaceuticals, will be Mr. Adam Wasserman, Chief Financial Officer.

To participate in this live conference call, please dial 866 800-8648 five to ten minutes prior to the scheduled conference call time. International callers should dial 617 614-2702. The conference Passcode is 151 721 84.

For those who are unable to participate in the conference call at the time of the call, a replay will be available for fourteen days starting on November 18, at 11:00 a.m. Eastern Standard Time. To access the replay, please dial 888 286-8010. International callers should dial 617 801-6888. The replay Passcode is 346 912 68.

About Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc. controls and operates Liangfang Pharmaceutical Company, Ltd. ("Liang Fang") and En Ze Jia Shi Pharmaceutical Company, Ltd. ("En Ze"), two pharmaceutical companies located in Beijing, China. Together, Liang Fang and En Ze form an operating company (together, "Lotus East"). Lotus East engages in the development of new drugs, drug manufacturing, and the marketing and sales of pharmaceuticals. read more